Sex- and hepatocyte PPARγ-dependent effects of an obesogenic dietary approach to induce MASH with fibrosis in mice
- 1Department of Medicine. Division of Endocrinology, Diabetes and Metabolism. University of Illinois Chicago, Chicago. IL.
Abstract
Mouse models of metabolic dysfunction-associated steatotic liver disease (MASLD) are valuable tools for identifying novel molecular mechanisms that drive progression from MASLD to metabolic dysfunction-associated steatohepatitis (MASH). However, generating a clinically relevant MASLD/MASH mouse model with obesity and peripheral metabolic dysfunction remains a challenge. In this study, we fed two different MASH-inducing diets to male mice with pre-existing high-fat (HF) diet-induced obesity. While a HF diet containing 40% Kcal from fat (mostly corn-oil shortening), 2% cholesterol, and 22% fructose reduced adiposity in these mice, a high-fat diet with 60% Kcal from fat (mostly lard), containing 2% cholesterol and supplemented with 10% fructose in the drinking water (HFC+Fr diet) promoted body weight and fat mass gain. Of note, 24 weeks of the HFC+Fr diet induced obesity, metabolic dysfunction, and liver steatosis in male and female mice, and promoted MASH with fibrosis in male mice. Furthermore, the HFC+Fr diet increased the expression of hepatocyte peroxisome proliferator-activated receptor γ ( Pparg ), but the knockout of Pparg in hepatocytes ( Pparg ΔHep ) reduced the development of MASH and fibrosis in male mice. In addition, the expression of key hepatic genes involved in methionine metabolism was downregulated by the HFC+Fr diet and upregulated by Pparg ΔHep only in male mice. Overall, the HFC+Fr diet is obesogenic and promotes MASLD in both male and female mice. However, the HFC+Fr diet promotes MASH in a sex- and hepatocyte Pparg -specific manner, which may be associated with downregulation of hepatic methionine metabolism. New & Noteworthy We explored how a new dietary intervention with fructose in the drinking water and added cholesterol to a high-fat diet extensively used to induce obesity and insulin resistance, promotes the onset of MASLD with obesity and metabolic dysfunction in male and female mice. This clinically relevant model of MASLD shows increased expression of hepatocyte PPARγ in both male and female mice, but only male mice have PPARγ-dependent impaired methionine metabolism and develop MASH with fibrosis.
Related
- Dietary context and ethanol-related injury in preclinical models: A contemporary systematic review of predominantly obesogenic diets and liver outcomes
- Hepatocyte protection and stellate cell control by Salvia miltiorrhiza in liver fibrosis
- Repeated instillations of bleomycin in male mice induce a perivascular remodeling at distance of fibrotic areas in the context of progressive pulmonary fibrosis
- Multi-cohort and single-nucleus transcriptomics identify a five-gene lactylation-related panel and a disease-dependent hepatocyte glycolysis-lactylation-related expression program in metabolic dysfunction-associated steatohepatitis.
- Anti-PLA2R autoantibodies induce complement activation via IgG subclass–dependent epitope pairings in membranous nephropathy
BibTeX
@article{sierracruz2026hepatocyte,
title = {{Sex- and hepatocyte PPARγ-dependent effects of an obesogenic dietary approach to induce MASH with fibrosis in mice}},
author = {Marta Sierra-Cruz and Izabela Hawro and Samuel M. Lee and Jose Muratalla and Jose Cordoba-Chacon},
journal = {American journal of physiology. Gastrointestinal and liver physiology},
year = {2026},
month = oct,
doi = {10.1152/ajpgi.00117.2026},
url = {https://doi.org/10.1152/ajpgi.00117.2026},
note = {CC BY},
}
RIS
TY - JOUR
TI - Sex- and hepatocyte PPARγ-dependent effects of an obesogenic dietary approach to induce MASH with fibrosis in mice
AU - Marta Sierra-Cruz
AU - Izabela Hawro
AU - Samuel M. Lee
AU - Jose Muratalla
AU - Jose Cordoba-Chacon
PY - 2026
DA - 2026/10/06
JO - American journal of physiology. Gastrointestinal and liver physiology
DO - 10.1152/ajpgi.00117.2026
UR - https://doi.org/10.1152/ajpgi.00117.2026
AB - Mouse models of metabolic dysfunction-associated steatotic liver disease (MASLD) are valuable tools for identifying novel molecular mechanisms that drive progression from MASLD to metabolic dysfunction-associated steatohepatitis (MASH). However, generating a clinically relevant MASLD/MASH mouse model with obesity and peripheral metabolic dysfunction remains a challenge. In this study, we fed two different MASH-inducing diets to male mice with pre-existing high-fat (HF) diet-induced obesity. While a HF diet containing 40% Kcal from fat (mostly corn-oil shortening), 2% cholesterol, and 22% fructose reduced adiposity in these mice, a high-fat diet with 60% Kcal from fat (mostly lard), containing 2% cholesterol and supplemented with 10% fructose in the drinking water (HFC+Fr diet) promoted body weight and fat mass gain. Of note, 24 weeks of the HFC+Fr diet induced obesity, metabolic dysfunction, and liver steatosis in male and female mice, and promoted MASH with fibrosis in male mice. Furthermore, the HFC+Fr diet increased the expression of hepatocyte peroxisome proliferator-activated receptor γ ( Pparg ), but the knockout of Pparg in hepatocytes ( Pparg ΔHep ) reduced the development of MASH and fibrosis in male mice. In addition, the expression of key hepatic genes involved in methionine metabolism was downregulated by the HFC+Fr diet and upregulated by Pparg ΔHep only in male mice. Overall, the HFC+Fr diet is obesogenic and promotes MASLD in both male and female mice. However, the HFC+Fr diet promotes MASH in a sex- and hepatocyte Pparg -specific manner, which may be associated with downregulation of hepatic methionine metabolism. New & Noteworthy We explored how a new dietary intervention with fructose in the drinking water and added cholesterol to a high-fat diet extensively used to induce obesity and insulin resistance, promotes the onset of MASLD with obesity and metabolic dysfunction in male and female mice. This clinically relevant model of MASLD shows increased expression of hepatocyte PPARγ in both male and female mice, but only male mice have PPARγ-dependent impaired methionine metabolism and develop MASH with fibrosis.
SN - 0193-1857
SN - 1522-1547
ER -